- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01228032
The Health Outcomes Management and Evaluation (HOME) Study (HOME)
Improving Primary Care of Patients With Mental Disorders
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Findings of excess cardiometabolic morbidity and mortality in persons with severe mental illness (SMI) have led to a growing interest by Community Mental Health Centers (CMHCs) in improving the medical care of the populations they treat. However, these organizations face a number of financial and organizational barriers to implementing and sustaining such programs. In previous and ongoing work, the study team has documented the promise of team-based models in improving health and health care in this population. This study will test a novel approach for improving mental health consumers based on a partnership model between a CMHC and a Community Health Center (CHC). This partnership will capitalize on collocation of services, the primary care expertise of the CHC, and favorable reimbursement conditions, to develop a program that is both clinically robust and financially and organizationally sustainable A total of 300 CMHC clients with a severe mental illness and one or more active cardiometabolic problem (diabetes, hypertension, hyperlipidemia) will be randomized to either onsite Integrated Community Care (ICC) (n=150) or to a referral to the partner community health center (CHC) (n=150) for their medical problems. For those in the ICC, the CHC will establish a satellite clinic at the CMHC staffed by a physician assistant and care manager. The ICC will provide care for both the index cardiometabolic conditions and common acute and chronic comorbidities.
The study will use standardized, validated instruments to assess the impact of integrated community care on quality and outcomes of cardiometabolic and general medical care. A budget impact analysis will be used to assess the program's financial and organizational sustainability. When this study is completed, it will provide a model for CMHCs to provide a medical home for the populations they serve.
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
Georgia
-
Marietta, Georgia, États-Unis, 30008
- Cobb County Community Service Board
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patient at Cobb County CSB
- one or more of the following conditions: hyperlipidemia, high blood pressure, heart failure, diabetes
- able to give consent
Exclusion Criteria:
- unable to give consent
- does not have a cardiometabolic condition
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Intervention
|
The ICC will provide care for both the index cardiometabolic conditions and common acute and chronic comorbidities.
Autres noms:
|
Aucune intervention: Control
referral only
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Quality of healthcare services received
Délai: 1 year
|
1 year
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Benjamin G Druss, MD MPH, Emory University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB00027782
- 2R01MH070437-06A1 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Care team
-
East Carolina UniversityPatient-Centered Outcomes Research Institute; University of North Carolina...Inscription sur invitation
-
University of Colorado, DenverInscription sur invitation
-
Seattle Children's HospitalUniversity of WashingtonActif, ne recrute pasAutisme | Intervention précoceÉtats-Unis
-
The Hospital for Sick ChildrenChild-Bright Network; Ehave; The Governors of the University of AlbertaRecrutementTDAH | TSA | CHD - Cardiopathie congénitaleCanada
-
VA Office of Research and DevelopmentMinneapolis Veterans Affairs Medical Center; Ralph H. Johnson VA Medical CenterInscription sur invitationTabagisme | Nodules pulmonaires multiples | Nodule pulmonaire solitaireÉtats-Unis
-
Munich Municipal HospitalTechnical University of Munich; University of RegensburgInconnueInfarctus cérébralAllemagne
-
University of RochesterUniversity at Buffalo; University of ArkansasRecrutementL'asthme chez les enfantsÉtats-Unis
-
The Hospital for Sick ChildrenEhave; Ontario Brain InstituteComplétéTrouble d'hyperactivité avec déficit de l'attentionCanada
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); ...RecrutementObésité | En surpoids | Poids | Perte de poids | Changements de poids corporel | Maladie chronique | Surpoids et obésité | Inactivité physique | Comportement, Manger | Perte de poidsÉtats-Unis
-
University of ManitobaJuvenile Diabetes Research Foundation; Canadian Institutes of Health Research...Pas encore de recrutementActivité physique | Diabète de type 1